International Vaccine Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:International Vaccine Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9332
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
International Vaccine Institute (IVI) is a non-profit organization that discovers, develops and delivers vaccines. The organization’s vaccines include bivalent inactivated oral cholera vaccine, Vi-DT typhoid conjugate vaccine, bivalent typhoid conjugate vaccine, shigella vaccine, norovirus vaccine, rotavirus vaccine, Vi-PspA conjugate vaccine. It develops vaccines for disease such as cholera, enteric fever, typhoid and dengue, and others. IVI conducts research on hepatitis E and provides support to partners in vaccine development for other diarrheal diseases including rotavirus, shigellosis, enterotoxigenic E. coli, norovirus, tuberculosis, and pneumococcal disease. IVI offers vaccine discovery and design, vaccine development and research services. The organization’s research services include collection of epidemiologic, economic and socio behavioral data, studies of vaccines feasibility and data synthesis and dissemination. IVI is headquartered in Seoul, South Korea.

International Vaccine Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Vaccine Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
International Vaccine Institute, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Indian Council of Medical Research to Enter into Agreement with International Vaccine Institute 10
MilliporeSigma Enters into Research Agreement with International Vaccine Institute 11
Incepta Vaccine Enters into Agreement with International Vaccine Institute 12
Intravacc Partners with International Vaccine Institute 13
SK Chemicals and International Vaccine Institute Enters into Agreement 14
Asset Transactions 15
PT Bio Farma Acquires Vaccine Technology from International Vaccine Institute 15
International Vaccine Institute – Key Competitors 16
International Vaccine Institute – Key Employees 17
International Vaccine Institute – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
International Vaccine Institute, Pharmaceuticals & Healthcare, Key Facts, 2016 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Vaccine Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Vaccine Institute, Deals By Therapy Area, 2012 to YTD 2018 8
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Indian Council of Medical Research to Enter into Agreement with International Vaccine Institute 10
MilliporeSigma Enters into Research Agreement with International Vaccine Institute 11
Incepta Vaccine Enters into Agreement with International Vaccine Institute 12
Intravacc Partners with International Vaccine Institute 13
SK Chemicals and International Vaccine Institute Enters into Agreement 14
PT Bio Farma Acquires Vaccine Technology from International Vaccine Institute 15
International Vaccine Institute, Key Competitors 16
International Vaccine Institute, Key Employees 17

List of Figures
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
International Vaccine Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[International Vaccine Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bharat Heavy Electricals Limited (BHEL):企業の戦略・SWOT・財務情報
    Bharat Heavy Electricals Limited (BHEL) - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Limited (BHEL) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Planmeca Oy:企業の戦略的SWOT分析
    Planmeca Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Maersk Line AS:企業の戦略的SWOT分析
    Maersk Line AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • National Australia Bank Limited:企業の戦略・SWOT・財務情報
    National Australia Bank Limited - Strategy, SWOT and Corporate Finance Report Summary National Australia Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • University of Pittsburgh:企業のM&A・事業提携・投資動向
    University of Pittsburgh - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Pittsburgh Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • CBS Corporation (CBS):企業の財務・戦略的SWOT分析
    CBS Corporation (CBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ImmunoGen Inc (IMGN):医療機器:M&Aディール及び事業提携情報
    Summary ImmunoGen Inc (ImmunoGen) is a clinical-stage biotechnology company that focuses on the development of antibody-drug conjugate therapies for the treatment of cancer. The company’s lead product candidate, mirvetuximab soravtansine, a folate receptor alpha (FRa) intended for the treatment of p …
  • Iridex Corp (IRIX):医療機器:M&Aディール及び事業提携情報
    Summary Iridex Corp (Iridex) is a medical device company that manufactures and distributes laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology and otolaryngology market. The company offers products such as lasers, laser delivery devices, glaucoma device …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • BMG Resources Ltd (BMG):企業の財務・戦略的SWOT分析
    Summary BMG Resources Ltd (BMG), formerly known as Brazilian Metals Group Ltd, is a mineral exploration company that explores lithium brine in Chile. The company's portfolio includes exploration tenements located in the Republic of Cyprus. Its product portfolio include nickel, gold, copper, cobalt, …
  • Vanderbilt University:製薬・医療:M&Aディール及び事業提携情報
    Summary Vanderbilt University (Vanderbilt) is a medical and research university that provides professional degrees. The university offers graduate and undergraduate degrees in the fields of engineering, music, liberal arts and sciences, education and human development. It provides services such as c …
  • SSM Health Care:企業の戦略的SWOT分析
    SSM Health Care - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • The Scripps Research Institute-製薬・医療分野:企業M&A・提携分析
    Summary The Scripps Research Institute (TSRI) is a research and educational organization that conducts research in the areas of neurosciences, cardiovascular diseases, immunology, autoimmune diseases, chemistry, molecular and cellular biology, virology and synthetic vaccine development. The institut …
  • Quantum Corp (QTM):企業の財務・戦略的SWOT分析
    Summary Quantum Corp (Quantum) is a technology company that offers intelligent solutions for capturing, sharing and preserving digital assets over the data lifecycle. The company provides products such as stornext scale-out storage, Q-cloud archive, quantum archives, scalar , LTO Tape Drives, DXi de …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis) formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Energiequelle GmbH-エネルギー分野:企業M&A・提携分析
    Summary Energiequelle GmbH (Energiequelle) is a renewable energy company that provides turnkey system services to wind, biogas, and solar energy projects. Its offerings include planning and construction services: identification of project site, negotiation, and construction of project; and grid conn …
  • PeptiDream Inc (4587):企業の財務・戦略的SWOT分析
    Summary PeptiDream Inc (PeptiDream) operates as a biopharmaceutical company. It discovers and develops peptides, peptide-drug, small molecule based, and conjugate therapeutics to address unmet medical needs. The company provides a proprietary peptide discovery platform system (PDPS), a versatile dis …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Phu Hung Securities Company:企業の戦略的SWOT分析
    Phu Hung Securities Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Oxiteno SA Industria E Comercio:企業の戦略的SWOT分析
    Oxiteno SA Industria E Comercio - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆